List of Tables
Table 1. Prostate Cancer Drugs Market Trends
Table 2. Prostate Cancer Drugs Market Drivers & Opportunity
Table 3. Prostate Cancer Drugs Market Challenges
Table 4. Prostate Cancer Drugs Market Restraints
Table 5. Global Prostate Cancer Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Prostate Cancer Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Prostate Cancer Drugs Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Prostate Cancer Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Prostate Cancer Drugs Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Prostate Cancer Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Prostate Cancer Drugs
Table 13. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Prostate Cancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Prostate Cancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Prostate Cancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Prostate Cancer Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Prostate Cancer Drugs Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Prostate Cancer Drugs Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Prostate Cancer Drugs Price by Type (2019-2024) & (USD/MT)
Table 27. Global Prostate Cancer Drugs Price by Type (2025-2030) & (USD/MT)
Table 28. Global Prostate Cancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Prostate Cancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Prostate Cancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Prostate Cancer Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Prostate Cancer Drugs Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Prostate Cancer Drugs Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Prostate Cancer Drugs Price by Application (2019-2024) & (USD/MT)
Table 39. Global Prostate Cancer Drugs Price by Application (2025-2030) & (USD/MT)
Table 40. Global Prostate Cancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Prostate Cancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Prostate Cancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Prostate Cancer Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Prostate Cancer Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Prostate Cancer Drugs Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Prostate Cancer Drugs Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Prostate Cancer Drugs Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Prostate Cancer Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Prostate Cancer Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Prostate Cancer Drugs Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Prostate Cancer Drugs Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Prostate Cancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Prostate Cancer Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Prostate Cancer Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Prostate Cancer Drugs Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Prostate Cancer Drugs Sales Volume, (2025-2030) & (K MT)
Table 57. AbbVie Company Information
Table 58. AbbVie Introduction and Business Overview
Table 59. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. AbbVie Prostate Cancer Drugs Product Offerings
Table 61. AbbVie Recent Development
Table 62. Astellas Pharma Company Information
Table 63. Astellas Pharma Introduction and Business Overview
Table 64. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Astellas Pharma Prostate Cancer Drugs Product Offerings
Table 66. Astellas Pharma Recent Development
Table 67. Astra Zeneca Company Information
Table 68. Astra Zeneca Introduction and Business Overview
Table 69. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Astra Zeneca Prostate Cancer Drugs Product Offerings
Table 71. Astra Zeneca Recent Development
Table 72. Johnson & Johnson Company Information
Table 73. Johnson & Johnson Introduction and Business Overview
Table 74. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Johnson & Johnson Prostate Cancer Drugs Product Offerings
Table 76. Johnson & Johnson Recent Development
Table 77. Sanofi Company Information
Table 78. Sanofi Introduction and Business Overview
Table 79. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Sanofi Prostate Cancer Drugs Product Offerings
Table 81. Sanofi Recent Development
Table 82. GlaxoSmithKline Company Information
Table 83. GlaxoSmithKline Introduction and Business Overview
Table 84. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. GlaxoSmithKline Prostate Cancer Drugs Product Offerings
Table 86. GlaxoSmithKline Recent Development
Table 87. Merck Group Company Information
Table 88. Merck Group Introduction and Business Overview
Table 89. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. Merck Group Prostate Cancer Drugs Product Offerings
Table 91. Merck Group Recent Development
Table 92. Novartis Company Information
Table 93. Novartis Introduction and Business Overview
Table 94. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. Novartis Prostate Cancer Drugs Product Offerings
Table 96. Novartis Recent Development
Table 97. Amgen Company Information
Table 98. Amgen Introduction and Business Overview
Table 99. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. Amgen Prostate Cancer Drugs Product Offerings
Table 101. Amgen Recent Development
Table 102. Bayer HealthCare Company Information
Table 103. Bayer HealthCare Introduction and Business Overview
Table 104. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. Bayer HealthCare Prostate Cancer Drugs Product Offerings
Table 106. Bayer HealthCare Recent Development
Table 107. Ferring Pharmaceutical Company Information
Table 108. Ferring Pharmaceutical Introduction and Business Overview
Table 109. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. Ferring Pharmaceutical Prostate Cancer Drugs Product Offerings
Table 111. Ferring Pharmaceutical Recent Development
Table 112. Janssen Pharmaceuticals Company Information
Table 113. Janssen Pharmaceuticals Introduction and Business Overview
Table 114. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Janssen Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 116. Janssen Pharmaceuticals Recent Development
Table 117. Endo Pharmaceuticals Company Information
Table 118. Endo Pharmaceuticals Introduction and Business Overview
Table 119. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 120. Endo Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 121. Endo Pharmaceuticals Recent Development
Table 122. BMS Company Information
Table 123. BMS Introduction and Business Overview
Table 124. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 125. BMS Prostate Cancer Drugs Product Offerings
Table 126. BMS Recent Development
Table 127. Takeda Pharmaceuticals Company Information
Table 128. Takeda Pharmaceuticals Introduction and Business Overview
Table 129. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 130. Takeda Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 131. Takeda Pharmaceuticals Recent Development
Table 132. Northwest Biotherapeutics Company Information
Table 133. Northwest Biotherapeutics Introduction and Business Overview
Table 134. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 135. Northwest Biotherapeutics Prostate Cancer Drugs Product Offerings
Table 136. Northwest Biotherapeutics Recent Development
Table 137. Teva Pharmaceutical Company Information
Table 138. Teva Pharmaceutical Introduction and Business Overview
Table 139. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 140. Teva Pharmaceutical Prostate Cancer Drugs Product Offerings
Table 141. Teva Pharmaceutical Recent Development
Table 142. Boehringer Ingelheim Company Information
Table 143. Boehringer Ingelheim Introduction and Business Overview
Table 144. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 145. Boehringer Ingelheim Prostate Cancer Drugs Product Offerings
Table 146. Boehringer Ingelheim Recent Development
Table 147. Foresee Pharmaceuticals Company Information
Table 148. Foresee Pharmaceuticals Introduction and Business Overview
Table 149. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 150. Foresee Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 151. Foresee Pharmaceuticals Recent Development
Table 152. Tokai Pharmaceuticals Company Information
Table 153. Tokai Pharmaceuticals Introduction and Business Overview
Table 154. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 155. Tokai Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 156. Tokai Pharmaceuticals Recent Development
Table 157. Spectrum Pharmaceuticals Company Information
Table 158. Spectrum Pharmaceuticals Introduction and Business Overview
Table 159. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 160. Spectrum Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 161. Spectrum Pharmaceuticals Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Prostate Cancer Drugs Downstream Customers
Table 165. Prostate Cancer Drugs Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Drugs Product Picture
Figure 2. Global Prostate Cancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Prostate Cancer Drugs Sales Volume (2019-2030) & (K MT)
Figure 5. Global Prostate Cancer Drugs Sales Price (2019-2030) & (USD/MT)
Figure 6. Prostate Cancer Drugs Report Years Considered
Figure 7. Global Prostate Cancer Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Prostate Cancer Drugs Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Cancer Drugs Revenue in 2023
Figure 10. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Hormonal Therapy Picture
Figure 12. Chemotherapy Picture
Figure 13. Immunotherapy Picture
Figure 14. Targeted Therapy Picture
Figure 15. Global Prostate Cancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Prostate Cancer Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Prostate Cancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 18. Global Prostate Cancer Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Prostate Cancer Drugs Price by Type (2019-2030) & (USD/MT)
Figure 20. Product Picture of Clinics
Figure 21. Product Picture of Hospitals
Figure 22. Product Picture of Others
Figure 23. Global Prostate Cancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Prostate Cancer Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Prostate Cancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 26. Global Prostate Cancer Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Prostate Cancer Drugs Price by Application (2019-2030) & (USD/MT)
Figure 28. North America Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Prostate Cancer Drugs Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Prostate Cancer Drugs Sales Volume (%), (2019-2030)
Figure 40. United States Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. China Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. China Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. India Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 60. India Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 61. Prostate Cancer Drugs Industrial Chain
Figure 62. Prostate Cancer Drugs Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed